Figure 5.
The number of cells that contained ubiquitin-positive inclusions in the 6-OHDA-lesioned striatum (A) and substantia nigra (B). Immunohistochemical examination of rat tissue using a ubiquitin antibody. Saline at 1 mL/kg (control) and mildronate at doses of 50 and 100 mg/kg were administered intraperitoneally for two weeks prior to the injection of 6-OHDA (20 μg) or artificial cerebrospinal fluid (aCSF); 6-OHDA injection in mildronate-treated rats: M50 + 6-OHDA and M100 + 6-OHDA. Striatum: * p = 0.001, SAL + 6-OHDA vs. SAL + aCSF; ** p = 0.001, M50 + 6-OHDA vs. SAL + 6-OHDA; S. nigra: *** p = 0.01, M100 + 6-OHDA vs. SAL + 6-OHDA; unpaired t-test. Number of animals per group (n = 8).